These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ☑ | Filed by the Registrant | ☐ | Filed by a party other than the Registrant | ||||||||
|
CHECK THE APPROPRIATE BOX:
|
|||||
|
☐
|
Preliminary Proxy Statement
|
||||
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
||||
|
☑
|
Definitive Proxy Statement
|
||||
|
☐
|
Definitive Additional Materials
|
||||
|
☐
|
Soliciting Material under §240.14a-12
|
||||
|
PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY):
|
|||||
|
☑
|
No fee required
|
||||
|
☐
|
Fee paid previously with preliminary materials
|
||||
|
☐
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
||||
|
3
|
|||||||
|
United Parcel Service, Inc.
55 Glenlake Parkway, N.E. Atlanta, GA 30328
March 17, 2025
Dear Fellow Shareowners,
|
|
||||
|
4
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
Notice of Annual Meeting
UNITED PARCEL SERVICE, INC.
55 Glenlake Parkway, N.E., Atlanta, Georgia 30328
|
||||
|
By order of the Board of Directors
|
|||||
|
Norman M. Brothers, Jr.
Secretary Atlanta, Georgia March 17, 2025 |
|||||
|
5
|
|||||||
|
Items of Business
UNITED PARCEL SERVICE, INC.
2025 Annual Meeting of Shareowners
|
||||
|
Voting Choices
|
Board Voting
Recommendations
|
Page | |||||||||
| Company Proposals: | |||||||||||
|
1.
Elect 12 director nominees named in the Proxy Statement to serve until the 2026 Annual Meeting and until their respective successors are elected and qualified
|
•
Vote for all nominees
•
Vote against all nominees
•
Vote for some nominees and against others
•
Abstain from voting on one or more nominees
|
FOR
EACH NOMINEE |
|||||||||
|
2.
Advisory vote to approve named executive officer compensation
|
•
Vote for the proposal
•
Vote against the proposal
•
Abstain from voting on the proposal
|
FOR | |||||||||
|
3.
Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2025
|
•
Vote for ratification
•
Vote against ratification
•
Abstain from voting on the proposal
|
FOR | |||||||||
| Shareowner Proposals: | |||||||||||
|
4. - 5. Advisory votes on 2 shareowner proposals, only if properly presented
|
•
Vote for each proposal
•
Vote against each proposal
•
Abstain from voting on one or more proposals
|
AGAINST
EACH PROPOSAL |
|||||||||
|
6
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
Proxy Statement
UNITED PARCEL SERVICE, INC.
55 Glenlake Parkway, N.E., Atlanta, Georgia 30328
|
||||
|
Corporate Governance
|
||
|
7
|
|||||||
|
2025 Director Nominees
|
||
|
92%
Independent
|
8.4 years
Av
erage tenure
|
||||||||||
| Name |
Director
Since |
Principal Occupation | Committee(s) | ||||||||
| Independent Directors | |||||||||||
| Rodney Adkins | 2013 |
Former Senior Vice President, IBM
|
–
Risk (Chair)
–
Compensation and Human Capital
–
Executive
|
||||||||
| Eva Boratto | 2020 |
Chief Financial Officer, Bath & Body Works
|
–
Audit (Chair)
|
||||||||
|
Kevin Clark
|
2025
|
Chairman and Chief Executive Officer, Aptiv
|
–
Audit
(1)
|
||||||||
| Wayne Hewett | 2020 |
Senior Advisor to Permira
|
–
Audit
|
||||||||
| Angela Hwang | 2020 |
Chief Executive Officer - Partner, Flagship Pioneering, and Chief Executive Officer, Metaphore Biotechnologies
|
–
Audit
|
||||||||
| Kate Johnson | 2020 |
President and Chief Executive Officer, Lumen Technologies
|
–
Nominating and Corporate Governance
–
Risk
|
||||||||
|
William Johnson
(2)
|
2009 |
Former Chairman, President and Chief Executive Officer, H.J. Heinz
|
–
Nominating and Corporate Governance (Chair)
–
Executive
|
||||||||
| Franck Moison | 2017 |
Former Vice Chairman, Colgate-Palmolive
|
–
Nominating and Corporate Governance
–
Risk
|
||||||||
| Christiana Smith Shi | 2018 |
Former President, Direct-to-Consumer, Nike
|
–
Compensation and Human Capital (Chair)
–
Risk
|
||||||||
| Russell Stokes | 2020 |
President and Chief Executive Officer, Commercial Engines and Services, GE Aerospace
|
–
Compensation and Human Capital
–
Nominating and Corporate Governance
|
||||||||
| Kevin Warsh | 2012 | Former Member of the Board of Governors of the Federal Reserve System, Distinguished Visiting Fellow, Hoover Institution, Stanford University |
–
Compensation and Human Capital
–
Nominating and Corporate Governance
|
||||||||
| Non-Independent Director | |||||||||||
| Carol Tomé | 2003 |
Chief Executive Officer, UPS
|
–
Executive (Chair)
|
||||||||
|
8
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Executive Compensation | ||
| Say on Pay Vote | ||
| Ratify the Appointment of the Independent Registered Public Accounting Firm | ||
| Shareowner Proposals | ||
|
9
|
|||||||
| Corporate Governance | ||
| Nomination Process | ||
|
1.
|
Board Composition Review
|
||||
|
The board’s annual self-evaluation process helps the Nominating and Corporate Governance Committee identify needs by
assessing areas where additional expertise, skills or experience may be desired
. The Nominating and Corporate Governance Committee also conducts regular board composition reviews.
|
|||||
|
2.
|
Candidate Identification
|
||||
|
The Nominating and Corporate Governance Committee uses a variety of sources to identify potential candidates, including board members, members of management, independent consultants and shareowner recommendations. Prospective candidates are evaluated after taking into account feedback from consultants, management and board members, candidate background and qualification reviews, and open discussions between the Nominating and Corporate Governance Committee and the full board. This process allows for
active consideration
of potential directors with a
focus on long-
term
Company strategy, and resulted in the appointment of Kevin Clark as a
new director in March 2025
.
|
|||||
|
3.
|
Shortlisted Candidates
|
||||
|
The Nominating and Corporate Governance Committee maintains a diverse list of potential director candidates according to desired skills, experiences and backgrounds.
The list is reviewed at each Nominating and Corporate Governance Committee meeting and updated as appropriate. Each candidate is evaluated to help ensure that existing and planned future commitments would not materially interfere with expected board responsibilities. This process led to the appointment of Kevin Clark to the board in March 2025.
|
|||||
|
4.
|
Recommendation, Nomination and Election
|
||||
|
Candidates recommended by the Nominating and Corporate Governance Committee and approved by the board are nominated for election.
Directors are elected annually
.
|
|||||
| Result: |
Six new independent directors added since 2020; 50% director refreshment since 2020.
|
||||
|
10
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
Shareowner Recommendations
|
||
|
11
|
|||||||
|
Annual Evaluation Process
|
||
|
1.
|
Formal Annual Evaluation Oversight
|
||||
|
The Board of Directors, Audit Committee, Compensation and Human Capital Committee, Nominating and Corporate Governance Committee, and Risk Committee each conduct an annual, formal self-assessment. The Nominating and Corporate Governance Committee oversees the annual board assessment process and the implementation of the annual committee self-assessments.
|
|||||
|
2.
|
Use of Detailed Questionnaires
|
||||
|
All board and committee members complete a detailed confidential questionnaire each year. The questionnaire provides for quantitative ratings in key areas, including overall board effectiveness, meeting effectiveness, access to information, information format, board committee structure, access to management, succession planning, meeting dialogue, communication with the CEO, operational reporting, financial oversight, capital structure and financing, capital spending, long-term strategic planning, risk oversight, crisis management and time management. In addition to responding to specific questions, directors are encouraged to provide additional written feedback and make detailed anonymous comments. We engage an independent third party to administer and prepare reports on the evaluations.
|
|||||
|
3.
|
Reviews
|
||||
|
The results of the committee self-assessments are reviewed by each committee and discussed with the full board. The Nominating and Corporate Governance Committee Chair reviews the results of committee self-assessments and discusses the responses with the chairs of the other board committees as appropriate. The Nominating and Corporate Governance Committee Chair also reviews and discusses the board evaluation results with the full board.
|
|||||
|
4.
|
Follow-up
|
||||
|
Matters requiring follow-up are addressed by the Nominating and Corporate Governance Committee Chair or the chairs of the other committees as appropriate. In addition, throughout the year the Board Chair meets individually with each director to discuss issues that are important to board members and to solicit further feedback.
|
|||||
|
Result:
|
Feedback from these evaluations has led to several improvements in board functionality, including changes to the format and delivery of board meeting materials, board meeting agendas and recurring topics, strategic planning and oversight, director recruitment practices, orientation and education, engagement with management, board committee memberships, allocation of responsibilities among the board’s committees and succession planning.
|
||||
|
12
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
8.4 years
nominee average tenure
|
|||||
|
Newer
directors (< 5 years)
|
|
||||
|
Medium-tenured
directors (5-10 years)
|
|
||||
|
Longer-tenured
directors (> 10 years)
|
|
||||
|
13
|
|||||||
| Board of Directors | |||||||||||
| Risk Committee | Audit Committee |
Compensation and Human
Capital Committee |
Nominating and Corporate
Governance Committee |
||||||||
|
Oversees management’s identification and evaluation of enterprise risks, including risks associated with intellectual property, operations, privacy, technology, cybersecurity and business continuity.
|
Oversees policies with respect to financial risk assessment, including guidelines to govern the process by which major financial and accounting risk assessment and management is undertaken.
|
Considers risks related to compensation policies and practices, with respect to both executive compensation and compensation generally, and considers other human capital risks.
|
Considers risks related to succession planning, political contributions and lobbying, environmental sustainability and stakeholder engagement matters, among others.
|
||||||||
|
14
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
|
|||||||||||||
|
We consider the views of our shareowners and other stakeholders when evaluating our policies and practices; for example, in recent years we have:
|
The Compensation and Human Capital Committee considers shareowner feedback, along with the market information and analysis provided by its independent compensation consultant, when making decisions about our executive compensation programs. In recent years we have:
|
|||||||||||||
|
•
Announced a number of environmental and social goals, including a carbon neutral by 2050 goal;
•
Accelerated our environmental sustainability reporting;
•
Increased disclosures around individual director skills, experience and backgrounds;
•
Separated the Board Chair and CEO roles;
•
Appointed an independent Board Chair;
•
Expanded reporting on lobbying activities;
•
Revised the Risk Committee charter to specifically identify cybersecurity oversight responsibilities;
•
Revised the Nominating and Corporate Governance Committee charter to include oversight of environmental sustainability matters and risks; and
•
Revised the Compensation and Human Capital Committee charter to include oversight of performance and talent management, workforce representation, work culture and employee development and retention.
|
•
Updated the peer group for executive and director compensation market comparisons;
•
Returned to a single, annual goal setting process for MIP awards;
•
Annually reevaluated performance metrics under our incentive compensation plans for proper design to incent towards long-term Company value creation;
•
Amended the MIP to adopt payout tables increasing clarity for participants and removing payout discretion;
•
Added relative total shareowner return as a component of our LTIP program;
•
Added an individual payout cap to the MIP;
•
Provided additional disclosures around the performance measures used for the MIP and LTIP plans;
•
Adopted a mandatory incentive compensation clawback policy applicable to executive officers;
•
Eliminated single-trigger equity vesting following a change in control; and
•
Enhanced the competitiveness of our annual MIP.
|
|||||||||||||
|
15
|
|||||||
| Overview | ||
| Oversight and Processes | ||
| Lobbying and Trade Associations | ||
| Political Activity Transparency | ||
|
16
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
17
|
|||||||
|
Oversight and Management
|
||
|
Total Rewards
|
||
|
Employee Health and Safety
|
||
|
18
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
19
|
|||||||
|
20
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Our Board of Directors | ||
|
What am I voting on?
Election of each of the 12 named director nominees to hold office until the 2026 Annual Meeting and until their respective successors are elected and qualified.
Board’s Recommendation:
Vote
FOR
the election of each nominee.
Vote Required:
A director will be elected if the number of votes cast for that director exceeds the number of votes cast against that director.
|
||
|
21
|
|||||||
|
92%
Independent
|
8.4 years
Av
erage tenure
|
||||||||||
|
Skills and
Experience / Attributes
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||
| CEO | l | l | l | l | l | l | ||||||||||||||||||||||||||||||||
| CFO | l | l | l | |||||||||||||||||||||||||||||||||||
| Consumer / Retail | l | l | l | l | l | |||||||||||||||||||||||||||||||||
| Digital Technology | l | l | l | l | ||||||||||||||||||||||||||||||||||
| Geopolitical Risk | l | l | l | |||||||||||||||||||||||||||||||||||
| Global / International | l | l | l | l | l | l | l | l | ||||||||||||||||||||||||||||||
| Healthcare | l | l | l | l | ||||||||||||||||||||||||||||||||||
|
Human Capital
Management
|
l | l | l | l | l | l | ||||||||||||||||||||||||||||||||
| Operational | l | l | l | l | l | l | l | l | l | |||||||||||||||||||||||||||||
|
Risk / Compliance /
Government
|
l | l | l | l | l | l | l | |||||||||||||||||||||||||||||||
| Sales / Marketing | l | l | l | l | l | l | ||||||||||||||||||||||||||||||||
|
Small and Medium-
Sized Businesses
|
l
|
l | l | l | l | l | ||||||||||||||||||||||||||||||||
|
Supply Chain
Management
|
l | l | l | l | l | l | l | |||||||||||||||||||||||||||||||
|
Technology /
Technology Strategy
|
l | l | l | l | l | |||||||||||||||||||||||||||||||||
|
Other Public
Company
Board Service
|
l | l | l | l | l | l | l | l | l | |||||||||||||||||||||||||||||
|
22
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
Reasons for Nomination
Rod brings deep expertise in technologies, business operations and supply chain management to the Board. He previously led corporate strategy and systems and technology groups at IBM, where he guided that company through continuous transformation and developed strategies for leadership in evolving computing capabilities, new markets and new client segments, delivering significant shareholder value.
Inducted into the National Academy of Engineering, he was recognized by the National Society of Black Engineers for Lifetime Achievement in Industry.
Select Skills and Experiences
•
Operational:
Rod led global teams and managed a multi billion-dollar product development and manufacturing business division at IBM, overseeing
the highly complex product lifecycle from concept and testing to commercialization. He drove efficient supply chain management, built high-performing teams and delivered high-
quality products across global markets.
•
Risk / Compliance / Government:
Throughout his 30-year career at IBM, Rod was responsible for
overseeing the integration of regulatory compliance and risk management into new product and service offerings development, facilitating robust intellectual property protection, adherence to export controls, consumer safety and the ethical use of emerging technologies
.
•
Technology / Technology Strategy:
Rod oversaw the creation of a wide portfolio of industry-transforming personal computing products, including the launch of mobile computing technologies and other products. He also led IBM’s POWER business and delivered market leadership for UNIX, pioneering what became IBM’s portfolio of IoT solutions.
|
Professional Highlights
3RAM Group LLC,
a capital investment, business consulting and property management services
•
President (since 2015)
International Business Machines (IBM),
a global technology products and services company
•
SVP, Corporate Strategy (2013-2014), Systems and Technology Group (2009-2013), Development & Manufacturing (2007-2009)
•
VP, Development, IBM Systems and Technology Group (2003-2007)
•
Several operational and executive roles spanning strategy, technology, systems and supply chain (1981-2003)
Education
•
B.A., Physics, Rollins College
•
B.S. and M.S., Electrical Engineering, Georgia Institute of Technology
|
||||||
|
Rodney Adkins
Independent Director
Director Since:
2013
Age:
66
Board Committees
•
Risk (Chair)
•
Compensation and Human Capital
•
Executive
Public Board Directorships
•
Avnet, Inc. (since 2015)
•
PayPal Holdings, Inc. (since 2017)
•
W.W. Grainger, Inc. (since 2014)
|
||||||||
|
23
|
|||||||
|
Reasons for Nomination
Eva brings extensive corporate finance experience to the Board, gained throughout her career as CFO at multiple public companies, including in the healthcare and retail sectors, with complex operations and large workforce. She has deep knowledge of financial reporting and accounting standards, organic and inorganic growth strategies and digital transformation. Her strong track record of creating shareholder value and building strong partnerships enhances the Board’s oversight of growth initiatives, compliance and financial risk management.
Select Skills and Experiences
•
Financial Expertise:
Eva has over three decades of experience in corporate finance roles, overseeing all aspects of corporate financial strategy and operations, including financial reporting, investor relations, capital strategies and procurement. While at CVS, she led the integration of the finance function following the acquisition of Aetna in 2018, unlocking synergies and positioning the company to realize growth.
•
Healthcare:
At CVS, Eva was critical to the development of that company’s growth plan, including investment in digital transformation. Her deep understanding of the healthcare sector enabled her to successfully lead that company through the COVID-19 pandemic, mitigating economic impact on operations and funding CVS Health’s capabilities to reaffirm its leadership role in testing and vaccines, while delivering on pre-established commitments and new business opportunities.
•
Risk / Compliance / Governance:
Throughout her career, Eva has played an instrumental role at leading public companies, overseeing operational and financial risk management, as well as compliance with tax and industry regulations. She has led the implementation of risk mitigation strategies to address both short-
and long-term challenges, along with the adoption of robust internal controls and compliance frameworks.
|
Professional Highlights
Bath & Body Works, Inc.,
a global personal care and home fragrance retailer
•
CFO (since 2023)
Opentrons Labworks, Inc.,
a life sciences company
•
CFO (2022-2023)
CVS Health Corporation,
a diversified health services company
•
EVP and CFO (2018-2021)
•
EVP, Controller and Chief Accounting Officer (2013-2018)
•
SVP and CFO, Pharmacy Services Segment (Caremark) (2010-2013)
Merck & Co.,
a global science and technology company
•
VP U.S. Market Finance Leader (2009-2010)
•
VP Investor Relations (2008-2009)
•
Global Pharmaceuticals VP & Controller (2006-2008)
•
Additional roles of increasing responsibility (1990-2006)
Education
•
B.S., Accounting and Economics, Rutgers University
•
MBA, Drexel University
|
||||||
|
Eva Boratto
Independent Director
Director Since:
2020
Age:
58
Board Committees
•
Audit (Chair)
|
||||||||
|
24
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
Reasons for Nomination
Kevin is a highly accomplished leader of complex, global organizations with a record of driving shareholder value through operating excellence, transformative change, and innovation aligned with dynamic landscapes and customers’ critical needs. Under his guidance, Aptiv evolved from an automotive components supplier into a premier full-systems solutions partner serving automotive, commercial vehicle, aerospace and defense, telecommunications and industrial markets around the world.
Select Skills and Experiences
•
Technology / Technology Strategy:
As CEO of Aptiv, Kevin led its transformation into a global technology company focused on advancing the future of mobility and positioned to capitalize on key megatrends, including electrification, digitization, artificial intelligence and automation. In addition, as CFO of Fisher Scientific, he guided the creation of a complete portfolio of products, services and solutions for health science research, discovery and diagnostics organizations worldwide.
•
CFO / Finance:
Kevin is an experienced operationally-focused finance executive with expertise in the industrial and healthcare sectors and a track record of driving profitable growth through disciplined risk management, operating efficiency and cost rationalization initiatives, as well as capital allocation strategies that include organic investments and M&A. His various CFO leadership has included overseeing two IPOs and multiple M&A transactions, including the completion of a $10 billion merger.
•
Supply Chain Management:
In his executive roles, Kevin has developed manufacturing and distribution effectiveness and efficiency plans for global enterprises serving more than 150 countries across six continents. His track record includes navigating supply chain disruptions caused by the COVID-19 pandemic and mitigating other macroeconomic and geopolitical risks. At Delphi and Aptiv, he transformed the manufacturing footprint through modernization and automation, enhancing operational resiliency and unlocking efficiencies.
|
Professional Highlights
Aptiv PLC,
a global full-system architecture and software solutions provider
•
Chairman and CEO (since 2022)
•
President and CEO (2017-2022)
Delphi Automotive,
global supplier of technologies for the automotive and commercial vehicle markets (Aptiv predecessor)
•
President and CEO (2015-2017)
•
EVP and COO (2014-2015)
•
EVP and CFO (2010-2014)
Liberty Lane Partners,
a private equity investment firm
•
Founding Partner (2007-2010)
Fisher Scientific International, Inc.,
a global manufacturer and distributor of products and solutions for scientific research and healthcare related companies
•
VP and CFO (2001-2006)
Education
•
B.S., Finance Administration, Michigan State University
•
MBA, Michigan State University
|
||||||
|
Kevin Clark
Independent Director
Director Since:
2025
Age:
62
Board Committees
•
Audit
(1)
Public Board Directorships
•
Aptiv (since 2015)
|
||||||||
|
(1)
If elected, Kevin will join the Audit Committee following the Annual Meeting.
|
||||||||
|
25
|
|||||||
|
Reasons for Nomination
Wayne brings extensive experience in global operations, finance, capital markets and packaging solutions, acquired through his senior executive leadership roles across the U.S., Europe, Latin America and the Asia-Pacific region. He has a proven track record of executing company-wide initiatives across large organizations, negotiating M&A transactions, developing proprietary products, optimizing supply chains and applying emerging technologies to introduce new products and services.
Select Skills and Experiences
•
Small and Medium-Sized Businesses:
Wayne’s corporate leadership experience across a range of small-, mid- and large-cap companies, along with his current work with the Permira executive team to drive growth and long-term value creation across the fund’s portfolio companies, provides him with deep insights into the expectations of a broad range of customers.
•
Supply Chain Management:
Among his various roles at GE, Wayne oversaw supply chain and operations. He launched and led the company-wide Operations Council,
which served as GE’s center of excellence for supply chain optimization, delivering enhancements for on-
time delivery, quality and environment, health and safety.
•
Technology / Technology Strategy:
While at GE, Wayne shifted the products portfolio to better serve differentiated customer needs, increasing profit and driving growth in emerging markets. At Lytx, he has successfully overseen the introduction capabilities that have enhanced that company’s customer solutions through advanced technologies.
|
Professional Highlights
Permira,
a global private equity firm
•
Senior Advisor (since 2018)
Klöckner Pentaplast Group,
a packaging supplier
•
CEO and Board Member (2015-2017)
Platform Specialty Products Corporation,
a global producer of high technology specialty chemical products
•
President and Board Member (2015)
Arysta LifeScience Corporation,
a crop protection and life science company
•
President, CEO and Board Member (2010-2015)
General Electric Company (“GE”),
a global industrial company
•
VP, Supply Chain and Operations (2007
-2010
)
•
President and CEO, GE Advanced Materials (2005-2006), GE Silicones (2003-2005)
•
President, GE Plastics Pacific (2001-2003)
•
President and CEO, GE Toshiba Silicones (2000-2001)
•
Additional roles
of increasing responsibilities (1986-2000
)
Education
•
B.S., Industrial Engineering
•
MBA, Stanford University
|
||||||
|
Wayne Hewett
Independent Director
Director Since:
2020
Age:
60
Board Committees
•
Audit
Public Board Directorships
•
Home Depot, Inc. (since 2014)
•
Wells Fargo & Company (since 2019)
Other Notable Affiliations
•
Hexion Chemicals (Lead Director since 2023)
•
Cambrex Corporation (Non-
Executive Chairman since 2020)
•
Lytx, Inc. (Board Member 2021-2025)
•
Quotient Sciences (Non-
Executive Chairman since 2023)
•
DiversiTech Corporation (Non-Executive Chairman 2018-2021)
|
||||||||
|
26
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
Reasons for Nomination
Angela is an experienced senior executive in the healthcare sector, with nearly three decades of experience managing complex businesses with a focus on research and development, commercial sales, supply chain and distribution logistics. She brings deep expertise in navigating M&A, post-acquisition integrations and leading operations in domestic, international and emerging markets. Angela’s experience provides critical contributions to board oversight of our global business operations and deepens the understanding of the evolving expectations of our healthcare clients. Further, her multiple roles in leading business and commercial operations, including oversight of business financials, brings an important lens to the board and the Audit Committee.
Select Skills and Experiences
•
Global / International:
As Chief Commercial Officer for a global biopharmaceuticals business at Pfizer, Angela led operations across 185 countries, with oversight responsibilities for the distribution of over 600 medicines that reached more than 1.3 billion people globally. In this role, she built and expanded collaborations with health insurers, governments, policymakers, and global health stakeholders to advance medicines accessibility.
•
Healthcare:
Angela played a critical role in the launch of the first COVID-19 vaccine and the first oral antiviral treatment a year later, securing rapid expansion of temperature-sensitive and time-critical distribution logistics. Through her extensive experience working across different segments of the healthcare industry, including biotechnology, she developed deep insights into fast-paced pharmaceutical innovation, enhancing the board’s oversight of our complex healthcare logistics services globally.
•
Sales / Marketing:
In her role as Chief Commercial Officer at Pfizer, she led global sales and marketing teams, overseeing marketing strategies and building multiple partnerships to grow and expand product portfolio.
|
Professional Highlights
Flagship Pioneering,
a bioplatform innovation company
•
CEO-Partner (since 2025)
•
CEO, Metaphore Biotechnologies (Flagship-founded biotechnology company) (since 2025)
Pfizer, Inc.,
a multinational pharmaceutical and biotechnology company
•
Chief Commercial Officer, President, Global Biopharmaceuticals Business (2019-2023)
•
Group President, Essential Health (2018)
•
Global President, Inflammation and Immunology (2015-2017)
•
Regional President, Vaccines US (2014-2015)
•
VP, Primary Care, Emerging Markets (2011-2013)
•
VP, Established Products US (2008-2011)
•
Additional roles of increasing responsibility (1997-2008)
Education
•
B.S., Microbiology, University of Cape Town
•
MBA, Cornell University, Johnson School of Management
|
||||||
|
Angela Hwang
Independent Director
Director Since:
2020
Age:
59
Board Committees
•
Audit
Other Notable Affiliations
•
Connecticut Innovations (Board Member)
•
Cornell Johnson School of Management Advisory Council
|
||||||||
|
27
|
|||||||
|
Reasons for Nomination
Kate is a highly skilled executive with significant digital and technology insight garnered through her accomplished career in the sector. She has a proven track record of driving business efficiency and digital transformation success at some of the world’s top Fortune 100 technology companies, both domestically and globally, serving business and mass-market customers. The board benefits from her strong commercial orientation, strategic experience and technical acumen.
Select Skills and Experiences
•
Digital Technology:
As the President and CEO of Lumen Technologies, Kate leads that company’s integration of network assets, cloud connectivity, security solutions and voice and collaboration tools that enable customers to manage secure, on-
demand connections from a single platform.
•
Technology / Technology Strategy:
At Microsoft, Kate was responsible for the growth of the company’s U.S. solutions, services and support revenues, advising both public and private sector clients on their technology strategies and implementation. She focused on driving transformation in Microsoft’s largest sales subsidiary where she led a 10,000-person field organization.
•
Sales / Marketing:
Kate sat on the Global Sales and Marketing leadership team at Microsoft and improved commercial intensity in the U.S. subsidiary to drive record-setting cloud revenue growth and customer adoption. At GE, Kate was responsible for building commercial capability for Enterprise Solutions, Intelligent Platforms and GE Digital.
|
Professional Highlights
Lumen Technologies,
a global technology and communications company
•
President and CEO (since 2022)
Microsoft Corporation,
a multinational technology company
•
President, Microsoft U.S. (2017-2021)
General Electric Company,
a global industrial company
•
EVP and Chief Commercial Officer, GE Digital (2016-2017)
•
CEO, GE Intelligent Platforms Software (2015-2016)
•
VP and Chief Commercial Officer (2013-2015)
Oracle,
a leading database management company
•
SVP, North America Technology and Government Consulting (2007-2013)
Education
•
B.S. Electrical Engineering, Lehigh University
•
MBA Finance, University of Pennsylvania Wharton School
|
||||||
|
Kate Johnson
Independent Director
Director Since:
2020
Age:
57
Board Committees
•
Nominating and Corporate Governance
•
Risk
Public Board Directorships
•
Lumen Technologies (since 2022)
|
||||||||
|
28
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
Reasons for Nomination
Bill brings over 30 years of executive leadership experience, along with expertise in complex global business operations and logistics, investment and risk management strategies and labor relations. His track record of successfully leading brand development and deep insights into the retail and consumer industries provide invaluable contributions to the board’s oversight of our strategy and risk management.
Building on his extensive public company board experience, Bill has held several leadership roles on our board, developing a deep understanding of our strategy, culture, and operations to support informed decision-making and organizational resilience. His experience in leading boards has been invaluable.
Select Skills and Experiences
•
Consumer / Retail:
Through his career-long experience at Heinz, including 15 years as President and CEO, Bill played a pivotal role in that company’s growth and transformation, strengthening its market position through strategic acquisitions and restructuring its global brand portfolio. Under his leadership, the company achieved significant sales growth across six continents.
•
Global / International:
Bill led multiple international divisions of Heinz, including operations in the Asia-Pacific, spanning Australia, New Zealand, China, Thailand and South Korea. He oversaw several international strategic acquisitions, significantly expanding that company’s global presence and driving international revenue growth.
•
Human Capital Management:
While overseeing global operations at Heinz, Bill executed talent strategies that supported that company’s international expansion, fostered a high-performance culture, built a diverse global talent pipeline, enhanced retention strategies and effectively managed labor relations. He was also instrumental in establishing and building Sovos Brands into a high growth CPG company.
|
Professional Highlights
Advent International Corporation,
a global private equity firm
•
Operating Partner, Global Retail and Consumer (since 2014)
Trian Fund Management, L.P.,
an investment management firm
•
Advisory Partner (2015-2017)
H.J. Heinz Company,
a global foods manufacturer
•
President and CEO (1998-2013) and Chairman (2000-2013)
•
President and COO (1996-1998)
•
S
VP, Asia-Pacific Operations (1993–1996
)
•
Additional roles of increasing responsibility (1982-1993)
Additional management roles with progressive scope of responsibilities:
Drackett
(a specialty consumer household products company),
Ralston Purina
(an animal and pet food, consumer products holding company) and
Anderson-Clayton
(a commodities trading company)
Education
•
B.S., University of California, Los Angeles
•
MBA, University of Texas at Austin
|
||||||
|
William Johnson
Independent Board Chair
Director Since:
2009
Age:
76
Board Committees
•
Nominating and Corporate Governance (Chair)
•
Executive
Public Board Directorships
•
Sovos Brands, Inc. (2017-2024)
•
PepsiCo, Inc
.
(2015-2020)
|
||||||||
|
29
|
|||||||
|
Reasons for Nomination
Franck is a highly accomplished executive with a successful track record of managing complex supply chains and enabling efficient operations that supported the growth and profitability of multinational business operations. He has extensive experience navigating global markets and developing strategic initiatives that enhance market positioning and customer engagement. Franck contributes a deep understanding of the evolving global landscape and shifting consumer preferences to support our board’s discussions related to international operations and risk management.
Select Skills and Experiences
•
Consumer / Retail:
Through his career-long tenure at Colgate, Franck successfully led operations and marketing, product innovation, talent, M&A and global brand management. He addressed customers’ needs through the acquisitions of several premium brands that are among Colgate’s most successful today.
•
Global / International:
Franck led Colgate’s operations in Asia, the South Pacific and Latin America. As COO of Emerging Markets, he led fast-growing international businesses, oversaw strategic acquisitions in Europe and other emerging markets and expanded that company’s geographic footprint.
•
Supply Chain Management:
During his time as President, Global Marketing, R&D and Supply Chain at Colgate, Franck was responsible for that company’s global supply chain and production capabilities, overseeing a large workforce of employees across a significant number of international factories, optimizing efficiency and creating flexibility to serve local market requirements.
|
Professional Highlights
Colgate-Palmolive Company,
a global consumer products company
•
Vice Chairman (2016-2018)
•
COO, Emerging Markets (2010-2016)
•
President, Global Marketing, R&D and Supply Chain (2007-2010)
•
President, Western Europe, Central Europe and South Pacific (2005-2007)
•
Additional management positions of increasing responsibility (1978-2005)
Education
•
Master’s Degree, Marketing, EDHEC Business School
•
MBA, Stephen M. Ross School of Business, University of Michigan
|
||||||
|
Franck Moison
Independent Director
Director Since:
2017
Age:
71
Board Committees
•
Nominating and Corporate Governance
•
Risk
Public Board Directorships
•
VusionGroup SA (since 2020)
•
Hanesbrands Inc. (since 2015)
Other Notable Affiliations
•
SomaLogic, Board Member (2019 - 2021)
•
EDHEC Business School (Paris, London, Singapore), Chairman of the International Advisory Board
•
McDonough School of Business, Georgetown University, International Board member
|
||||||||
|
30
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
Reasons for Nomination
As a recognized leader in the retail sector, Christiana brings deep experience in consumer marketing and distribution strategy, digital transformation and e-commerce, as well as a track record of successfully driving large-scale operational change in global labor-intensive organizations. Building on her extensive public company board experience, Christiana utilizes her ov
er 35 years of retail and consumer industry experience to inform her vital contributions to the board’s oversight of our technology, marketing and distribution strategy and operations.
Select Skills and Experiences
•
Consumer / Retail:
During her time at Nike, Christiana played an instrumental role overseeing the expansion of the company’s direct-to-consumer business. Under her leadership, Nike direct-to-consumer global revenues increased significantly. Christiana also brings extensive retail experience from her time at McKinsey, where she helped to create and extend the firm’s proprietary knowledge in merchandising, omnichannel and e-commerce, global strategy and lean store operations.
•
Digital Technology:
In her various leadership roles at Nike, Christiana oversaw integrated global e-commerce strategy and led the accelerated growth of Nike’s digital commerce and customer engagement capabilities. Now, as the Founder and Principal of Lovejoy Advisors, LLC, she focuses on advising consumer and retail businesses on digital transformations.
•
Operational:
Christiana is an experienced operator of large multichannel retail organizations, providing strong supply chain and cost management expertise in the global consumer industry. During her nearly 25 years at McKinsey, she worked across developed and emerging markets providing global leadership, expertise and strategic vision to senior executives of consumer companies, including designing and leading transformation programs, developing cross-
channel marketing and merchandising programs and driving successful market entry and expansion strategies.
|
Professional Highlights
Lovejoy Advisors, LLC,
an advisory services firm that assists clients with digitally transforming consumer and retail businesses
•
Founder and Principal (since 2016)
Nike, Inc.,
a global designer, marketer and distributor of athletic apparel
•
President, Direct-to-Consumer (2013-2016)
•
Vice President and General Manager, Global Digital Commerce (2012-2013)
•
VP and COO, Global Direct-to-Consumer (2010-2012)
McKinsey & Company,
a global management consulting firm
•
Director and Senior Partner (2000-2010)
•
Additional management positions of increasing responsibility (1986-2000)
Additional management roles of progressive scope of responsibilities:
Merrill Lynch & Company
(an American investment and wealth management company)
Education
•
B.A., International Relations and Economics, Stanford University
•
MBA, Harvard Business School
|
||||||
|
Christiana Smith Shi
Independent Director
Director Since:
2018
Age:
65
Board Committees
•
Compensation and Human Capital (Chair)
•
Risk
Public Board Directorships
•
Columbia Sportswear Company (since 2022)
•
Williams Sonoma, Inc. (2017-2019)
•
Mondelez International, Inc. (2016-2023)
|
||||||||
|
31
|
|||||||
|
Reasons for Nomination
Russell is a proven executive leader in operations,
logistics
, global supply chain management and labor relations. Through his long career in aerospace engineering and integrated systems manufacturing, he has established a successful track record of executing mission-critical strategies that deliver increased value to shareholders and enhance competitiveness. He brings extensive experience that contributes to the board oversight of effective transportation fleet management, sustainable operations and business transformation by moving complex business issues into focused, targeted actions for improvement.
Select Skills and Experiences
•
Technology / Technology Strategy:
In his current role as President and CEO of the Commercial Engines and Services division at GE Aerospace, Russell leads that company's strategy on technology, solutions and services across the energy value chain, from the point of generation to consumption. Throughout his time at GE, Russell has gained valuable experience working on engineering and integration of innovative sustainable energy solutions, which contributes valuable insights to the board oversight of our fleet electrification and energy transition strategy.
•
Operational:
During his tenure at GE, Russell has overseen operations as President and CEO of five GE businesses, including Aviation Services, Power, Energy Connections and Transportation. Across his over 25-year career at GE, he has experience leading through market cycles and navigating multiple industries and business segments.
•
Sales / Marketing:
Russell gained valuable experience in sales and marketing through various roles at GE. This includes serving as President and CEO of GE Aviation Services, where he was responsible for commercial growth, operating performance and customer experience across its global Overhaul and Repair footprint.
|
Professional Highlights
GE Aerospace,
a global aerospace propulsion, services, and systems leader
•
President and CEO, Commercial Engines and Services (Since 2022)
General Electric Company,
a multinational conglomerate with aerospace, energy, healthcare, and finance divisions
•
President and CEO, GE Aviation Services (2020-2022)
•
President and CEO, GE Power Portfolio (2019-2020), GE Power (2017-2019), GE Energy Connections (2015-2017), GE Transportation (2013-2015)
•
Additional management roles of increasing responsibility at GE Transportation and GE Aviation
(1997-
2013)
Education
•
B.B.A., Finance, Cleveland State University
|
||||||
|
Russell Stokes
Independent Director
Director Since:
2020
Age:
53
Board
Committees
•
Compensation and Human Capital
•
Nominating and Corporate Governance
Other Notable Affiliations
•
Metro Atlanta Chamber of Commerce Executive Committee
•
Atlanta Committee for Progress
|
||||||||
|
32
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
Reasons for Nomination
Carol is a recognized consumer and retail industry executive with a successful track record of managing labor-intensive, complex organizations, driving growth, developing talent and successfully executing strategic priorities. Building on her extensive public company board experience, Carol applies her deep institutional knowledge, financial expertise and broader industry insights, enhancing board discussions on critical priorities and evolving market risks.
Select Skills and Experiences
•
Financial Expertise:
Gained through her nearly two decades of senior leadership at Home Depot, where she served as that company’s CFO, Carol has in-depth knowledge of logistics, corporate finance, risk and compliance. She oversaw financial reporting, planning and analysis, internal audit, investor relations and tax, as well as strategy and business development, IT and cybersecurity. Under her leadership as CFO, Home Depot delivered a significant increase in shareholder value and sales grew substantially.
•
Human Capital Management:
While overseeing global operations at UPS, Carol has spearheaded initiatives to improve employee experience and maintain a strong talent pipeline, including successfully managing complex labor union negotiations.
•
Consumer / Retail:
During her career at Home Depot, Carol drove that company’s transformation into one of the world’s largest retailers, reinvigorating the consumer business, and growing B2B sector, despite a challenging macroenvironment during the financial recession and housing crisis. At UPS, she enhanced B2B segment profitability through automated technologies and enhanced distribution networks to improve delivery volumes.
|
Professional Highlights
United Parcel Service
•
CEO (since 2020)
The Home Depot, Inc.,
one of the world’s largest retailers
•
EVP and CFO (2001-2019)
•
SVP, Finance and Treasurer (1999-2001)
•
VP and Treasurer (1995-1999)
Johns-Manville, Inc.,
a manufacturer of insulation and building products
•
Director of Banking (1992-1995)
United Bank of Denver,
now Wells Fargo & Company
•
Commercial Lender (1981-1992)
Education
•
B.A., Communication, University of Wyoming
•
MBA, University of Denver
|
||||||
|
Carol B. Tomé
Chief Executive Officer and Director
Director Since:
2003
Age:
68
Board Committees
•
Executive
Public Board Directorships
•
Verizon Communications, Inc. (since 2021)
•
Cisco Systems, Inc. (2019-2020)
Other Notable Affiliations
•
Atlanta Committee for Progress (Chair and Board Member)
•
Grady Memorial Hospital Corporation (Board Member)
•
Federal Reserve Bank of Atlanta (Board Member 2008 -2013, Board Chair 2010 - 2012)
|
||||||||
|
33
|
|||||||
|
Reasons for Nomination
Kevin is a distinguished political advisor and economist, bringing a deep expertise in the global financial and business environment, as well as significant experience working in the private sector for a leading global investment bank. As a former central banker, presidential advisor and financial markets expert, he contributes to the board his extensive understanding of economic policies, public affairs and geopolitical dynamics.
Select Skills and Experiences
•
Financial Expertise:
As a member of the Federal Reserve’s board, Kevin focused on financial and economic developments and monetary policies. In this position, he played a significant role in navigating the global financial crisis in 2008. In his earlier career, he was a member of the Mergers & Acquisitions team at Morgan Stanley, developing strong expertise in financial analysis and strategic growth initiatives.
•
Risk / Compliance / Government:
Kevin served as a special assistant to President George W. Bush for economic policy and as executive secretary at the National Economic Council. During his time at the White House, he advised the President and senior administration officials on issues related to the U.S. economy, capital markets, securities, banking, and insurance issues.
•
Geopolitical Risk:
During Kevin’s time as a member of the Federal Reserve board, he served as the Fed’s representative to the Group of Twenty (G-20), consisting of the world’s largest 20 economies, and as the Fed’s emissary to the emerging and advanced economies in Asia. Additionally, Kevin is broadly recognized as an expert in global monetary policy and international financial markets, including in his current role as a Distinguished Visiting Fellow in Economics at the Hoover Institute.
|
Professional Highlights
Stanford University
•
Shepard Family Distinguished Visiting Fellow in Economics at the Hoover Institution, a public policy think tank (since 2012)
•
Dean’s Visiting Scholar and lecturer at the Graduate School of Business (since 2011)
Duquesne Family Office LLC,
the investment firm of Stanley F. Druckenmiller
•
Advisor / Partner (since 2011)
Federal Reserve Board of Governors
•
Member (2006-2011)
The White House Administration of President George W. Bush
•
Special Assistant for Economic Policy and Executive Secretary of the National Economic Council (2002-2006)
Morgan Stanley & Co.,
a leading global financial services firm
•
VP and Executive Director of Mergers and Acquisitions (
1995-2002
)
Education
•
A.B., Public Policy, Stanford University
•
J.D., Harvard Law School
|
||||||
|
Kevin M. Warsh
Independent Director
Director Since:
2012
Age:
54
Board Committees
•
Compensation and Human Capital
•
Nominating and Corporate Governance
Public Board Directorships
•
Coupang, Inc. (since 2019)
Other Notable Affiliations
•
Group of Thirty (G30)
•
Congressional Budget Office, Panel of Economic Advisers
|
||||||||
|
34
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
35
|
|||||||
|
Audit Committee
(1)
|
Compensation and Human
Capital Committee
(2)
|
Nominating and Corporate
Governance Committee
|
Risk Committee | ||||||||
|
Eva Boratto, Chair
Michael Burns Wayne Hewett Angela Hwang |
Christiana Smith Shi, Chair
Rodney Adkins Russell Stokes Kevin Warsh |
William Johnson, Chair
Kate Johnson Franck Moison Russell Stokes Kevin Warsh |
Rodney Adkins, Chair
Kate Johnson Franck Moison Christiana Smith Shi |
||||||||
|
Meetings in 2024:
11
|
Meetings in 2024:
5
|
Meetings in 2024:
4
|
Meetings in 2024:
4
|
||||||||
| Primary Responsibilities |
Primary Responsibilities
|
Primary Responsibilities
|
Primary Responsibilities
|
||||||||
|
•
Assisting the board in discharging its responsibilities relating to our accounting, reporting and financial practices
•
Overseeing our accounting and financial reporting processes
•
Overseeing the integrity of our financial statements, our systems of disclosure controls and internal controls
•
Overseeing the performance of our internal audit function
•
Appointing and overseeing the performance of our independent accountants
•
Overseeing compliance with legal and regulatory requirements as well as our Code of Business Conduct
•
Discussing with management policies with respect to financial risk assessment
|
•
Assisting the board in discharging its responsibilities with respect to compensation of our senior executive officers
•
Reviewing and approving corporate goals and objectives relevant to the compensation of our CEO
•
Evaluating the CEO’s performance
•
Overseeing the evaluation of risks associated with our compensation strategy and programs
•
Overseeing any outside consultants retained to advise the committee
•
Recommending to the board the compensation for non-management directors
•
Overseeing performance and talent management, workforce representation, work culture and employee development and retention
|
•
Addressing succession planning
•
Assisting the board in identifying and screening qualified director candidates, including shareowner submitted candidates
•
Recommending candidates for election or reelection, or to fill vacancies, on the board
•
Aiding in attracting qualified candidates to serve on the board
•
Recommending corporate governance guidelines, including the structure, composition and functioning of the board and all board committees, the delegation of authority to subcommittees, board oversight of management
actions and reporting duties of management
•
Overseeing relevant environmental sustainability matters and related risks
|
•
Overseeing management’s identification and evaluation of enterprise risks
•
Overseeing and reviewing with management the Company’s risk governance framework
•
Overseeing risk identification, tolerance, assessment and management practices for strategic enterprise risks, including cybersecurity risks and cyber incident response
•
Reviewing approaches to risk assessment and mitigation strategies, in coordination with the board and other board committees
•
Communicating with the Audit Committee to enable it to perform its responsibilities with respect to oversight of risk assessment and risk management
|
||||||||
|
36
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| 2024 Director Compensation and Outstanding Stock Awards | ||
|
2024 Director Compensation
|
Outstanding Director Stock Awards
(as of December 31, 2024) |
||||||||||||||||||||||
| Name |
Fees Earned
or Paid
in Cash
($) |
Stock
Awards ($) (1) |
Total
($) |
Stock Awards | |||||||||||||||||||
| Name |
Restricted
Stock Units (#) |
Phantom
Stock Units (#) |
|||||||||||||||||||||
|
Rodney Adkins
(2)
|
140,000 | 185,000 | 325,000 | Rodney Adkins | 22,119 | — | |||||||||||||||||
|
Eva Boratto
(2)
|
145,000 | 185,000 | 330,000 | Eva Boratto | 5,398 | — | |||||||||||||||||
| Michael Burns | 120,000 | 185,000 | 305,000 | Michael Burns | 35,073 | — | |||||||||||||||||
| Wayne Hewett | 120,000 | 185,000 | 305,000 | Wayne Hewett | 5,398 | — | |||||||||||||||||
| Angela Hwang | 120,000 | 185,000 | 305,000 | Angela Hwang | 5,780 | — | |||||||||||||||||
| Kate Johnson | 120,000 | 185,000 | 305,000 | Kate Johnson | 5,056 | — | |||||||||||||||||
|
William Johnson
(2)(3)
|
300,000 | 255,000 | 555,000 | William Johnson | 38,347 | — | |||||||||||||||||
| Franck Moison | 120,000 | 185,000 | 305,000 | Franck Moison | 13,257 | — | |||||||||||||||||
|
Christiana Smith Shi
(2)
|
140,000 | 185,000 | 325,000 | Christiana Smith Shi | 11,165 | — | |||||||||||||||||
| Russell Stokes | 120,000 | 185,000 | 305,000 | Russell Stokes | 5,056 | — | |||||||||||||||||
| Kevin Warsh | 120,000 | 185,000 | 305,000 | Kevin Warsh | 24,406 | — | |||||||||||||||||
|
Carol Tomé
(4)
|
28,395 | 1,457 | |||||||||||||||||||||
|
37
|
|||||||
|
Executive Compensation
|
||
|
38
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
Named Executive Officer
|
Title | ||||
|
Carol Tomé
|
Chief Executive Officer | ||||
|
Brian Dykes
(1)
|
Chief Financial Officer
|
||||
|
Brian Newman
(1)
|
Former Chief Financial Officer
|
||||
| Nando Cesarone | President U.S. and UPS Airline | ||||
| Kate Gutmann | President International, Healthcare and Supply Chain Solutions | ||||
| Bala Subramanian | Chief Digital and Technology Officer | ||||
| Executive Compensation Strategy | ||
| Key Elements of UPS Executive Compensation | ||
|
39
|
|||||||
| Target Direct Compensation | ||
| Other Elements of Compensation | ||||||||||||||||||||
| Benefits | Perquisites | Retirement Programs | ||||||||||||||||||
|
ü
NEOs generally participate in the same plans as other employees.
ü
Includes medical, dental and disability plans.
ü
See further details on page
48
.
|
ü
Limited in nature; we believe benefits to the Company outweigh the costs.
ü
Includes financial planning and executive health services that facilitate the NEOs’ ability to carry out responsibilities, maximize working time and minimize distractions.
ü
Considered necessary or appropriate to attract and retain executive talent.
|
ü
NEOs and most non-union U.S. employees participate in the same qualified plans with the same formulas.
ü
Includes non-qualified and qualified pension, retirement savings and deferred compensation plans.
ü
See further details on page
48
.
|
||||||||||||||||||
|
40
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Roles and Responsibilities | ||
| Participant and Roles | ||
|
The Committee
•
develops executive compensation principles and strategy
•
sets incentive compensation performance goals
•
evaluates the CEO’s performance
•
reviews the CEO’s performance assessment of other executive officers
•
reviews and approves incentive and other compensation of the executive officers
•
oversees the risk evaluation associated with compensation strategy and programs
•
considers whether to engage any compensation consultant, and evaluates their independence
•
reviews and discusses the Compensation Discussion and Analysis with management
•
recommends to the board the inclusion of the Compensation Discussion and Analysis in the Proxy Statement
•
approves the inclusion of the Committee’s report on executive compensation in the Proxy Statement
|
||
|
Independent Members of the Board of Directors
•
review the Committee’s assessment of the CEO’s performance
•
complete a separate evaluation of the CEO’s performance
•
approve the Compensation Discussion and Analysis for inclusion in the Proxy Statement
|
||
|
Independent Compensation Consultant
•
serves as a resource for market data on pay practices and trends
•
provides independent advice to the Committee
•
provides competitive analysis and advice related to independent director compensation
•
reviews the Compensation Discussion and Analysis
•
conducts an annual risk assessment of the Company’s compensation programs
|
||
|
Executive Officers
•
CEO makes compensation recommendations to the Committee for the other executive officers
•
CEO and CFO recommend performance goals under incentive compensation plans and provide an assessment as to whether performance goals were achieved
|
||
| Compensation Consultant Independence | ||
|
41
|
|||||||
| Peer Group and Market Data Utilization | ||
|
AT&T, Inc.
|
FedEx Corporation | McDonald’s Corp. | ||||||
| The Boeing Company | The Home Depot, Inc. | PepsiCo, Inc. | ||||||
| Caterpillar Inc. | Intel Corporation | The Procter & Gamble Company | ||||||
| Cisco Systems, Inc. | Johnson & Johnson | Target Corp. | ||||||
| Comcast Corporation | Lockheed Martin Corporation | Walmart, Inc. | ||||||
| Deere & Company | Lowe’s Companies, Inc. | |||||||
| Internal Compensation Comparisons and Annual Performance Reviews | ||
| Base Salary | ||
|
42
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
Management Incentive Program Overview
|
||
| 2024 MIP Performance Metrics |
2024 MIP
Performance
Target
|
|||||||
|
Consolidated revenue
was considered important to generating profits and maintaining our long-term competitive positioning and viability.
|
$93.8B
|
|||||||
|
Consolidated non-GAAP adjusted operating profit
(1)
reflects our effectiveness in achieving our targets in other key performance elements, including volume growth and operating leverage.
|
$10.0B
|
|||||||
|
Total committed service
reflects our dependability in delivering packages on or before the time we promised.
|
96.1% | |||||||
|
43
|
|||||||
|
44
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
2024
MIP
Performance Metric
|
2024 MIP Performance
Target
|
Actual
Performance
|
Weighted Payout Score
(% of Target)
|
||||||||
| Consolidated Revenue | $93.8B | $91.1B | 41.9% | ||||||||
|
Consolidated non-GAAP Adjusted Operating Profit
|
$10.0B | $8.9B | 36.5% | ||||||||
|
Enterprise Total Committed Service
|
96.1% | 96.8% | 12.4% | ||||||||
|
2024 MIP Payout Factor =
|
91% | ||||||||||
| Name |
Incentive
Target (% Base Salary) |
Incentive
Target Value ($) |
2024 MIP Payout
Factor
(%)
|
Total 2024
MIP Award
Payout
($)
|
||||||||||
| Carol Tomé | 200 | 3,019,425 | 91% | 2,747,677 | ||||||||||
| Brian Dykes |
115
|
833,750 | 91% | 758,713 | ||||||||||
|
Brian Newman
(
1)
|
115 | 963,384 | 91% | 438,340 | ||||||||||
| Nando Cesarone | 115 | 1,004,944 | 91% | 914,499 | ||||||||||
| Kate Gutmann | 115 | 1,004,944 | 91% | 914,499 | ||||||||||
|
Bala Subramanian
|
115 | 915,808 | 91% | 833,385 | ||||||||||
| Long-Term Incentive Awards | ||
| Program |
Performance Measures and/
or Value Proposition for
2024 Awards
|
Payment Form and
Program Type
|
Program Objectives | ||||||||
| LTIP |
Non-GAAP Adjusted Earnings Per Share
Non-GAAP Adjusted Free Cash Flow
Relative Total Shareowner Return as a modifier
Value increases or decreases with stock price
|
If earned, RPUs are settled in stock
If earned, RPUs generally vest at the end of the three-year performance period
|
Supports long-term operating plan and business strategy
Significant link to shareowner interests
|
||||||||
| Stock Option |
Value recognized only if stock price appreciates
|
Stock options generally vest 20% per year over five years and have a ten-year term
|
Significant link to shareowner interests
Enhance stock ownership and shareowner alignment
|
||||||||
|
45
|
|||||||
| Name |
LTIP Target
RPU Value
(% Base Salary)
|
Stock Option
Value
(% Base Salary)
|
Total
Value
(% Base Salary)
|
||||||||
| Carol Tomé | 1,185 | 90 | 1,275 | ||||||||
| Brian Dykes |
450
|
20
(
1)
|
470
|
||||||||
| Brian Newman | 550 | 50 | 600 | ||||||||
| Nando Cesarone | 450 | 50 | 500 | ||||||||
| Kate Gutmann | 450 | 50 | 500 | ||||||||
| Bala Subramanian | 450 | 50 | 500 | ||||||||
|
46
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
RTSR Percentile Rank
Relative to Index
|
Payout
Modifier |
||||
|
Above 75
th
percentile
|
+20% | ||||
|
Between 25
th
and 75
th
percentile
|
None | ||||
|
Below 25
th
percentile
|
-20% | ||||
| 2022 LTIP Metrics | |||||||||||||||||||||||||||||||||||
|
Non-GAAP Adjusted Earnings Per Share (50%)
|
Non-GAAP Adjusted Free Cash Flow (50%)
|
RTSR | |||||||||||||||||||||||||||||||||
| Year | Threshold | Target | Maximum | Actual | Threshold | Target | Maximum | Actual | Actual | ||||||||||||||||||||||||||
| 2022 | 1.5% | 4.8% | 5.9% | 6.7% | $23,577 | $33,682 | $43,787 | $24,861 |
14th
|
||||||||||||||||||||||||||
| 2023 | 5.1% | (32.1)% | |||||||||||||||||||||||||||||||||
| 2024 | 3.8% | (12.1)% | |||||||||||||||||||||||||||||||||
| 2022 LTIP Final Results | |||||||||||||||||
| Performance Period | Non-GAAP Adjusted EPS Payout | Non-GAAP Adjusted FCF Payout | Performance Payout (Avg) | RTSR Modifier | Final Payout | ||||||||||||
|
2022-2024
|
67% | 56% | 62% | (20)% | 42% | ||||||||||||
|
47
|
|||||||
| Employment Transition Awards, Retention Arrangements and Recognition Awards | ||
| Benefits and Perquisites | ||
|
48
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Other Compensation and Governance Policies | ||
| CEO | = 8x annual salary | ||||
| Other Executive Officers | = 5x annual salary | ||||
|
Non-Employee Directors
|
= 5x annual retainer | ||||
|
49
|
|||||||
|
50
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Consideration of Previous “Say on Pay” Voting Results | ||
|
51
|
|||||||
|
Name and
Principal Position
|
Year |
Salary
($)
(1)
|
Bonus
($)
(2)
|
Stock
Awards
($)
(3)
|
Option
Awards
($)
(4)
|
Non-Equity
Incentive Plan
Compensation
($)
(5)
|
Change in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings
($)
(6)
|
All Other
Compensation
($)
(7)
|
Total
($)
|
||||||||||||||||||||
|
Carol Tomé
Chief Executive
Officer
|
2024
|
1,509,713 | — | 18,283,138 | 1,358,768 | 2,747,677 | — | 164,681 | 24,063,977 | ||||||||||||||||||||
| 2023 | 1,509,713 | — | 18,916,192 | 1,358,762 | 1,509,713 | — | 95,671 | 23,390,051 | |||||||||||||||||||||
| 2022 | 1,466,250 | — | 15,046,968 | 1,228,547 | 1,035,932 | — | 187,504 | 18,965,201 | |||||||||||||||||||||
|
Brian Dykes
Chief Financial
Officer
|
2024 | 619,553 | — | 2,500,130 | 103,515 | 758,713 | 0 | 117,856 | 4,099,767 | ||||||||||||||||||||
|
Brian Newman
Former Chief
Financial Officer
|
2024
|
349,052 | — | 4,708,740 | 418,893 | 438,340 | — | 1,900,756 | 7,815,781 | ||||||||||||||||||||
| 2023 | 831,626 | — | 5,551,095 | 406,692 | 481,692 | — | 70,965 | 7,342,070 | |||||||||||||||||||||
| 2022 | 784,377 | — | 5,563,543 | 382,755 | 364,363 | — | 94,203 | 7,189,241 | |||||||||||||||||||||
|
Nando Cesarone
President U.S. and
UPS Airline
|
2024
|
867,501 | — | 3,901,807 | 424,211 | 914,499 | — | 119,314 | 6,227,332 | ||||||||||||||||||||
| 2023 | 840,254 | — | 4,686,065 | 407,924 | 487,837 | — | 99,161 | 6,521,241 | |||||||||||||||||||||
| 2022 | 768,042 | — | 4,348,893 | 351,117 | 364,278 | — | 107,812 | 5,940,142 | |||||||||||||||||||||
|
Kate Gutmann
President
International,
Healthcare and
Supply Chain
Solutions
|
2024
|
867,501 | — | 3,901,807 | 424,211 | 914,499 | 0 | 148,472 | 6,256,490 | ||||||||||||||||||||
| 2023 | 840,254 | — | 4,686,065 | 407,924 | 487,837 | 3,786,483 | 152,958 | 10,361,521 | |||||||||||||||||||||
| 2022 | 781,197 | — | 4,674,444 | 377,426 | 364,278 | — | 20,676 | 6,218,021 | |||||||||||||||||||||
|
Bala Subramanian
Chief Digital and
Technology Officer
|
2024
|
790,556 | 250,000 | 3,555,753 | 386,601 | 833,385 | — | 79,671 | 5,895,966 | ||||||||||||||||||||
| 2023 | 766,622 | 500,000 | 4,139,164 | 373,540 | 444,566 | — | 76,370 | 6,300,262 | |||||||||||||||||||||
| 2022 | 330,853 |
250,000
|
6,928,392 | — | — | — | 932 | 7,510,177 | |||||||||||||||||||||
|
52
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Name |
401(k) Plan
Retirement
Contributions
(a)
($)
|
Restoration
Savings Plan
Contributions
(b)
($)
|
401(k)
Plan
Match
($)
|
Life
Insurance
Premiums
($)
|
Financial
Planning
Services
($)
|
Healthcare
Benefits
($)
|
Other
(c)
($)
|
Total
($)
|
||||||||||||||||||
| Carol Tomé | 17,250 | 93,177 | 10,350 | 22,246 | 15,000 | 6,658 | 164,681 | |||||||||||||||||||
| Brian Dykes | 27,600 | 57,341 | 10,350 | 1,033 | 14,874 | 6,658 | 117,856 | |||||||||||||||||||
| Brian Newman | 17,250 | 3,224 | 10,350 | 1,694 | 15,000 | 6,658 | 1,846,580 | 1,900,756 | ||||||||||||||||||
| Nando Cesarone | 27,600 | 57,475 | 10,350 | 2,256 | 14,975 | 6,658 | 119,314 | |||||||||||||||||||
| Kate Gutmann | 27,600 | 92,387 | 10,350 | 4,218 | 7,259 | 6,658 | 148,472 | |||||||||||||||||||
| Bala Subramanian | 17,250 | 35,644 | 10,350 | 2,044 | 7,725 | 6,658 | 79,671 | |||||||||||||||||||
|
53
|
|||||||
|
Grant
Date
|
Estimated Possible Payouts
Under Non-Equity Incentive
Plan Awards
(1)
|
Estimated Future Payouts
Under Equity Incentive
Plan Awards
(2)
|
All Other
Option
Awards:
Number of
Securities
Underlying
Options
(#)
(3)
|
Exercise
or Base
Price of
Option
Awards
($/Sh)
|
Grant
Date
Fair Value
of Stock
and
Option
Awards
($)
(4)
|
||||||||||||||||||||||||||||||
| Name |
Threshold
($)
|
Target
($)
|
Maximum
($)
|
Threshold
(#)
|
Target
(#)
|
Maximum
(#)
|
|||||||||||||||||||||||||||||
| Carol Tomé | — | 150,971 | 3,019,425 | 6,038,851 | — | — | — | — | — | — | |||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | 5,780 | 115,599 | 254,318 | — | — | 18,283,138 | ||||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | — | — | — | 39,090 |
154.76
|
1,358,768 | ||||||||||||||||||||||||||
| Brian Dykes | — | 41,688 | 833,750 | 1,667,500 | — | — | — | — | — | — | |||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | 334 | 6,688 | 14,714 | — | — | 1,057,774 | ||||||||||||||||||||||||||
|
9/30/2024
|
— | — | — | 554 | 11,078 | 24,372 | — | — | 1,442,356 | ||||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | — | — | — | 2,978 |
154.76
|
103,515 | ||||||||||||||||||||||||||
|
Brian
Newman
|
— | 48,169 | 963,384 | 1,926,768 | — | — | — | — | — | — | |||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | 1,489 | 29,772 | 65,498 | — | — | 4,708,740 | ||||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | — | — | — | 12,051 |
154.76
|
418,893 | ||||||||||||||||||||||||||
|
Nando
Cesarone
|
— | 50,247 | 1,004,944 | 2,009,887 | — | — | — | — | — | — | |||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | 1,234 | 24,670 | 54,274 | — | — | 3,901,807 | ||||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | — | — | — | 12,204 |
154.76
|
424,211 | ||||||||||||||||||||||||||
|
Kate
Gutmann
|
— | 50,247 | 1,004,944 | 2,009,887 | — | — | — | — | — | — | |||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | 1,234 | 24,670 | 54,274 | — | — | 3,901,807 | ||||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | — | — | — | 12,204 |
154.76
|
424,211 | ||||||||||||||||||||||||||
|
Bala
Subramanian
|
— | 45,790 | 915,808 | 1,831,616 | — | — | — | — | — | — | |||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | 1,124 | 22,482 | 49,460 | — | — | 3,555,753 | ||||||||||||||||||||||||||
|
3/20/2024
|
— | — | — | — | — | — | 11,122 |
154.76
|
386,601 | ||||||||||||||||||||||||||
|
54
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Option Awards | Stock Awards | |||||||||||||||||||||||||||||||
| Name |
Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
|
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)
(1)
|
Option
Exercise
Price
($)
|
Option
Grant
Date
|
Option
Expiration
Date
|
Number of
Shares or
Units of
Stock That
Have
Not Vested
(#)
(2)
|
Market
Value of
Shares or
Units of
Stock That
Have
Not Vested
($)
(3)
|
Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units or
Other
Rights
That
Have Not
Vested
(#)
(4)
|
Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights That
Have Not
Vested
($)
(3)
|
|||||||||||||||||||||||
| Carol Tomé | 81,008 | 20,253 | 99.28 | 6/1/2020 | 6/1/2030 | — | — | — | — | |||||||||||||||||||||||
| 28,571 | 19,048 | 165.66 | 2/10/2021 | 2/10/2031 | — | — | — | — | ||||||||||||||||||||||||
| 10,142 | 15,215 | 214.58 | 3/23/2022 | 3/23/2032 | — | — | — | — | ||||||||||||||||||||||||
| 6,615 | 26,461 |
185.54
|
3/22/2023
|
3/22/2033
|
— | — | — | — | ||||||||||||||||||||||||
| — | 39,090 |
154.76
|
3/20/2024
|
3/20/2034
|
— | — | — | — | ||||||||||||||||||||||||
| — | — | — |
—
|
—
|
— | — | 210,844 | 26,587,428 | ||||||||||||||||||||||||
| Brian Dykes | 1,465 |
977
|
165.66
|
2/10/2021
|
2/10/2031
|
— | — | — | — | |||||||||||||||||||||||
|
616
|
925
|
214.58
|
3/23/2022
|
3/23/2032
|
— | — | — | — | ||||||||||||||||||||||||
|
487
|
1,948 |
185.54
|
3/22/2023
|
3/22/2033
|
— | — | — | — | ||||||||||||||||||||||||
| — | 2,978 |
154.76
|
3/20/2024
|
3/20/2034
|
— | — | — | — | ||||||||||||||||||||||||
| — | — | — |
—
|
—
|
2,603 | 328,244 | 23,971 | 3,022,743 | ||||||||||||||||||||||||
| Brian Newman | 24,308 | — | 105.54 | 2/12/2020 |
6/1/2025
|
— | — | — | — | |||||||||||||||||||||||
| 9,483 | — | 165.66 | 2/10/2021 |
6/1/2025
|
— | — | — | — | ||||||||||||||||||||||||
| 3,160 | — |
214.58
|
3/23/2022 |
6/1/2025
|
— | — | — | — | ||||||||||||||||||||||||
| 1,980 | — | 185.54 | 3/22/2023 |
6/1/2025
|
— | — | — | — | ||||||||||||||||||||||||
| — | — | — |
—
|
—
|
— | — | 18,169 | 2,291,111 | ||||||||||||||||||||||||
| Nando Cesarone |
757
|
— | 106.43 | 3/1/2018 | 3/1/2028 | — | — | — | — | |||||||||||||||||||||||
|
633
|
— | 104.45 | 3/22/2018 | 3/22/2028 | — | — | — | — | ||||||||||||||||||||||||
| 3,383 | — | 111.80 | 2/14/2019 | 2/14/2029 | — | — | — | — | ||||||||||||||||||||||||
| 5,484 | 2,742 | 105.54 | 2/12/2020 | 2/12/2030 | — | — | — | — | ||||||||||||||||||||||||
| 5,308 | 5,308 | 165.66 | 2/10/2021 | 2/10/2031 | — | — | — | — | ||||||||||||||||||||||||
| 2,898 | 4,349 | 214.58 | 3/23/2022 | 3/23/2032 | — | — | — | — | ||||||||||||||||||||||||
| 1,986 | 7,944 |
185.54
|
3/22/2023
|
3/22/2033
|
— | — | — | — | ||||||||||||||||||||||||
| — | 12,204 |
154.76
|
3/20/2024
|
3/20/2034
|
— | — | — | — | ||||||||||||||||||||||||
| — | — | — |
—
|
—
|
— | — | 46,955 | 5,921,026 | ||||||||||||||||||||||||
| Kate Gutmann | 10,083 | — | 106.43 | 3/1/2018 | 3/1/2028 | — | — | — | — | |||||||||||||||||||||||
| 9,704 | — | 111.80 | 2/14/2019 | 2/14/2029 | — | — | — | — | ||||||||||||||||||||||||
| 12,051 | 3,013 | 105.54 | 2/12/2020 | 2/12/2030 | — | — | — | — | ||||||||||||||||||||||||
| 5,477 | 3,652 | 165.66 | 2/10/2021 | 2/10/2031 | — | — | — | — | ||||||||||||||||||||||||
| 3,994 | 2,663 | 163.25 | 3/25/2021 | 3/25/2031 | — | — | — | — | ||||||||||||||||||||||||
| 3,116 | 4,674 | 214.58 | 3/23/2022 | 3/23/2032 | — | — | — | — | ||||||||||||||||||||||||
| 1,986 | 7,944 |
185.54
|
3/22/2023 | 3/22/2033 | — | — | — | — | ||||||||||||||||||||||||
| — | 12,204 |
154.76
|
3/20/2024
|
3/20/2034
|
— | — | — | — | ||||||||||||||||||||||||
| — | — | — |
—
|
—
|
— | — | 46,955 | 5,921,026 | ||||||||||||||||||||||||
| Bala Subramanian | 1,818 | 7,275 |
185.54
|
3/22/2023
|
3/22/2033
|
— | — | — | — | |||||||||||||||||||||||
| — | 11,122 |
154.76
|
3/20/2024
|
3/20/2034
|
— | — | — | — | ||||||||||||||||||||||||
| — | — | — |
—
|
—
|
— | — | 42,884 | 5,407,672 | ||||||||||||||||||||||||
|
55
|
|||||||
| Option Awards | Stock Awards | ||||||||||||||||
| Name |
Number of
Shares
Acquired
on Exercise
(#)
|
Value
Realized
on Exercise
($)
|
Number of
Shares
Acquired
on Vesting
(#)
(1)
|
Value
Realized
on Vesting
($)
(2)
|
|||||||||||||
| Carol Tomé | — | — | 24,930 | 3,143,673 | |||||||||||||
| Brian Dykes | — | — | 2,886 | 401,746 | |||||||||||||
| Brian Newman | — | — | 7,675 | 967,818 | |||||||||||||
| Nando Cesarone | — | — | 6,912 | 871,603 | |||||||||||||
| Kate Gutmann | — | — | 8,021 | 1,030,092 | |||||||||||||
| Bala Subramanian | — | — | 16,768 | 2,282,285 | |||||||||||||
|
56
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Name | Plan Name |
Number of
Years
Credited
Service
(#)
(2)
|
Present
Value of
Accumulated
Benefit
($)
(3)
|
Payments
During
Last
Fiscal
Year
($)
|
||||||||||
|
Carol Tomé
(1)
|
UPS Retirement Plan | — | — | — | ||||||||||
| UPS Excess Coordinating Benefit Plan | — | — | — | |||||||||||
| Total |
|
— | — | |||||||||||
| Brian Dykes | UPS Retirement Plan |
22.58
|
472,431 | — | ||||||||||
| UPS Excess Coordinating Benefit Plan | — | — | ||||||||||||
| Total | — | |||||||||||||
|
Brian Newman
(1)
|
UPS Retirement Plan | — | — | — | ||||||||||
| UPS Excess Coordinating Benefit Plan | — | — | — | |||||||||||
| Total |
|
— | — | |||||||||||
|
Nando Cesarone
(1)
|
UPS Retirement Plan | — | — | — | ||||||||||
| UPS Excess Coordinating Benefit Plan | — | — | — | |||||||||||
| Total |
|
— | — | |||||||||||
| Kate Gutmann | UPS Retirement Plan | 33.0 | 1,397,389 | — | ||||||||||
| UPS Excess Coordinating Benefit Plan | 33.0 | 3,613,311 | — | |||||||||||
| Total |
|
5,010,700 | — | |||||||||||
|
Bala Subramanian
(1)
|
UPS Retirement Plan | — | — | — | ||||||||||
| UPS Excess Coordinating Benefit Plan | — | — | — | |||||||||||
| Total |
|
— | — | |||||||||||
|
57
|
|||||||
| Pension Benefits | ||
|
58
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Name | Plan Name |
Executive
Contributions
in Last FY
($)
(1)
|
Registrant
Contributions
in Last FY
($)
(2)
|
Aggregate
Earnings
in Last FY
($)
(3)
|
Aggregate
Withdrawals/
Distributions
($)
|
Aggregate
Balance at
Last FYE
($)
(4)
|
||||||||||||||
| Carol Tomé | UPS Deferred Compensation Plan | 1,976,422 | — | 784,131 | — | 10,678,487 | ||||||||||||||
| UPS Restoration Savings Plan | — | 93,177 | 4,238 | — | 297,080 | |||||||||||||||
| Outstanding Non-employee Director RSU Awards | — | — | (675,697) | — | 3,580,601 | |||||||||||||||
| Brian Dykes | UPS Deferred Compensation Plan | 30,978 | — | 21,999 | — | 162,439 | ||||||||||||||
| UPS Restoration Savings Plan | — | 57,341 | 4,556 | — | 52,086 | |||||||||||||||
| Brian Newman | UPS Restoration Savings Plan | — | 3,224 | 8,251 | 127,119 | — | ||||||||||||||
| Nando Cesarone | UPS Restoration Savings Plan | — | 57,475 | 8,767 | — | 207,212 | ||||||||||||||
| Kate Gutmann | UPS Deferred Compensation Plan | — | — | (51,173) | — | 402,804 | ||||||||||||||
| UPS Restoration Savings Plan | — | 92,387 | 5,939 | — | 105,493 | |||||||||||||||
| Bala Subramanian | UPS Restoration Savings Plan | — | 35,644 | 2,970 | — | 46,015 | ||||||||||||||
| Salary Deferral Feature | ||
| Stock Option Deferral Feature | ||
|
59
|
|||||||
| Withdrawals and Distributions under the UPS Deferred Compensation Plan | ||
| UPS Restoration Savings Plan | ||
|
60
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
61
|
|||||||
| Other Outstanding Awards; No Tax Gross-Ups | ||
| Name |
Separation
Pay
(1)
($)
|
Accelerated
/
Continued
Vesting of Equity
Awards
(2)
($)
|
Benefits
(3)
|
Total
($)
|
||||||||||
| Carol Tomé | ||||||||||||||
| Termination (voluntary or involuntary for cause) | — | — | — | — | ||||||||||
| Termination (involuntary without cause) | 9,079,636 | 12,686,122 | — | 21,765,758 | ||||||||||
| Change in Control (with qualifying termination) | 9,079,636 | 13,229,308 | — | 22,308,944 | ||||||||||
| Retirement | — | 13,229,308 | — | 13,229,308 | ||||||||||
| Death | — | 13,229,308 | — | 13,229,308 | ||||||||||
| Disability | — | 13,229,308 | — | 13,229,308 | ||||||||||
| Brian Dykes | ||||||||||||||
| Termination (voluntary or involuntary for cause) | — | — | — | — | ||||||||||
| Termination (involuntary without cause) | 1,590,365 | 1,580,543 | — | 3,170,908 | ||||||||||
| Change in Control (with qualifying termination) | 1,590,365 | 1,580,543 | — | 3,170,908 | ||||||||||
| Retirement | — | — | — | — | ||||||||||
| Death | — | 1,580,543 | — | 1,580,543 | ||||||||||
| Disability | — | 1,580,543 | — | 1,580,543 | ||||||||||
| Nando Cesarone | ||||||||||||||
| Termination (voluntary or involuntary for cause) | — | — | — | — | ||||||||||
| Termination (involuntary without cause) | 1,909,454 | 2,872,012 | — | 4,781,466 | ||||||||||
| Change in Control (with qualifying termination) | 1,909,454 | 2,928,387 | — | 4,837,841 | ||||||||||
| Retirement | — | — | — | — | ||||||||||
| Death | — | 2,928,387 | — | 2,928,387 | ||||||||||
| Disability | — | 2,928,387 | — | 2,928,387 | ||||||||||
| Kate Gutmann | ||||||||||||||
| Termination (voluntary or involuntary for cause) | — | — | — | — | ||||||||||
| Termination (involuntary without cause) | 1,910,330 | 2,872,012 | — | 4,782,342 | ||||||||||
| Change in Control (with qualifying termination) | 1,910,330 | 2,933,959 | — | 4,844,289 | ||||||||||
| Retirement | — | 2,933,959 | 748,094 | 3,682,053 | ||||||||||
| Death | — | 2,933,959 | — | 2,933,959 | ||||||||||
| Disability | — | 2,933,959 | — | 2,933,959 | ||||||||||
| Bala Subramanian | ||||||||||||||
| Termination (voluntary or involuntary for cause) | — | — | — | — | ||||||||||
| Termination (involuntary without cause) | 1,742,876 | 2,625,150 | — | 4,368,026 | ||||||||||
| Change in Control (with qualifying termination) | 1,742,876 | 2,625,150 | — | 4,368,026 | ||||||||||
| Retirement | — | — | — | — | ||||||||||
| Death | — | 2,625,150 | — | 2,625,150 | ||||||||||
| Disability | — | 2,625,150 | — | 2,625,150 | ||||||||||
|
62
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Other Amounts | ||
| Definition of a Change in Control | ||
|
Separation of Former Chief Financial Officer
|
||
|
63
|
|||||||
| Plan category |
Number of Securities
to be Issued
Upon Exercise of
Outstanding Options,
Warrants and Rights
(a)
|
Weighted-Average
Exercise Price of
Outstanding Options,
Warrants and Rights
($)(b)
|
Number of Securities
Remaining Available for Future
Issuance
Under Equity Compensation
Plans (Excluding Securities
Reflected in Column (a))
(c)
|
||||||||
|
Equity compensation plans approved by security holders
(1)
|
3,761,906 |
130.69
|
17,880,340
(2)
|
||||||||
| Equity compensation plans not approved by security holders | — | N/A | — | ||||||||
| Total | 3,761,906 |
130.69
|
17,880,340 | ||||||||
|
64
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
65
|
|||||||
|
Year
(1)
|
Summary
Comp
Table Total
for First PEO
($)
|
Summary
Comp
Table Total
for Second PEO
($)
|
Comp
Actually Paid
to First PEO
($)
|
Comp Actually Paid to Second PEO ($)
|
Average
Summary
Comp
Table Total
for Non-PEO
Named
Executive
Officers
($)
|
Average
Comp
Actually Paid
to Non-PEO
Named
Executive
Officers
($)
|
Value of Initial Fixed $100
Investment Based on:
|
Net Income
(GAAP)
(millions)
($)
|
Non-GAAP Adjusted Operating Profit
(3)
(millions)
($)
|
|||||||||||||||||||||||
|
Total
Shareholder
Return
($)
|
Peer Group
(2)
Total Shareholder
Return
($)
|
|||||||||||||||||||||||||||||||
| 2024 | N/A |
|
N/A |
|
|
|
|
|
|
|
||||||||||||||||||||||
| 2023 | N/A |
|
N/A |
|
|
|
|
|
|
|
||||||||||||||||||||||
| 2022 | N/A |
|
N/A |
|
|
|
|
|
|
|
||||||||||||||||||||||
| 2021 | N/A |
|
N/A |
|
|
|
|
|
|
|
||||||||||||||||||||||
| 2020 |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
PEO SCT Total to CAP Reconciliation
|
|||||||||||||||||
|
Year
|
Summary
Compensation
Table Total for
PEO
($)
|
Deductions from
SCT Total
(1)
($)
|
Additions and other adjustments to SCT
Total
(2)
($)
|
Compensation
Actually Paid
($)
|
|||||||||||||
| 2024 |
|
|
|
|
|||||||||||||
| 2023 |
|
|
|
|
|||||||||||||
|
2022
|
|
|
|
|
|||||||||||||
|
2021
|
|
|
|
|
|||||||||||||
|
2020
(3)
|
|
|
|
|
|||||||||||||
|
|
|
|
|
||||||||||||||
|
66
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
PEO Equity Component of CAP
|
|||||||||||||||||||||||
|
Year
|
Year End Fair Value of Equity Awards Granted in the Year
($) |
Change in Fair Value from Prior Year End to Year End of Outstanding Unvested Equity Awards Granted in Prior Years
($) |
Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year
($) |
Change in Fair Value from Prior Year End to Vesting Date of Equity Awards Granted in Prior Years that Vested in the Year
($) |
Fair Value as of Prior Year End of Equity Awards Forfeited in the Year
($)
|
Total Equity Award Adjustments
($) |
|||||||||||||||||
| 2024 |
|
(
|
|
(
|
|
|
|||||||||||||||||
| 2023 |
|
(
|
|
(
|
|
|
|||||||||||||||||
|
2022
|
|
(
|
|
|
|
|
|||||||||||||||||
|
2021
|
|
|
|
|
|
|
|||||||||||||||||
|
2020
(1)
|
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
(
|
|
||||||||||||||||||
|
Average Non-PEO NEOs SCT Total to CAP Reconciliation
|
|||||||||||||||||
|
Year
|
Summary
Compensation
Table Total for
Other NEOs
($)
|
Deductions from
SCT Total
(1)
($)
|
Additions and other adjustments to SCT
Total
(2)
($)
|
Compensation
Actually Paid
($)
|
|||||||||||||
| 2024 |
|
|
(
|
|
|||||||||||||
| 2023 |
|
|
|
|
|||||||||||||
|
2022
|
|
|
|
|
|||||||||||||
|
2021
|
|
|
|
|
|||||||||||||
|
2020
|
|
|
|
|
|||||||||||||
|
67
|
|||||||
|
Average Non-PEO NEOs Equity Component of CAP
|
|||||||||||||||||||||||
|
Year
|
Year End Fair Value of Equity Awards Granted in the Year
($) |
Change in Fair Value from Prior Year End to Year End of Outstanding Unvested Equity Awards Granted in Prior Years
($) |
Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year
($) |
Change in Fair Value from Prior Year End to Vesting Date of Equity Awards Granted in Prior Years that Vested in the Year
($) |
Fair Value as of Prior Year End of Equity Awards Forfeited in the Year
($)
|
Total Equity Award Adjustments
($) |
|||||||||||||||||
| 2024 |
|
(
|
|
(
|
(
|
(
|
|||||||||||||||||
| 2023 |
|
(
|
|
(
|
|
|
|||||||||||||||||
|
2022
|
|
(
|
|
|
|
|
|||||||||||||||||
|
2021
|
|
|
|
|
|
|
|||||||||||||||||
|
2020
|
|
|
|
|
(
|
|
|||||||||||||||||
|
Tabular List
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
68
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
69
|
|||||||
|
What am I voting on?
Whether you approve, on an advisory basis, the compensation of the NEOs as disclosed in this Proxy Statement.
Board’s Recommendation:
Vote
FOR
this proposal.
Vote Required:
Approval by a majority of the voting power of the shares present in person or by proxy.
|
||
|
70
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Ownership of Our Securities | ||
| Name and Address |
Number of Shares of Class B
Stock Beneficially Owned
|
Percent of Class B
Stock
|
||||||
|
BlackRock, Inc.
(1)
,
55 East 52nd Street,
New York, NY 10055
|
54,283,579
|
7.4%
|
||||||
|
The Vanguard Group
(2)
,
100 Vanguard Blvd.,
Malvern, PA 19355
|
67,218,177
|
9.2%
|
||||||
|
71
|
|||||||
|
Number of Shares
Beneficially
Owned
(1)
|
Total Shares
Beneficially
Owned
(4)
|
|||||||||||||
|
Class A Shares
(2)(3)
|
Class B Shares | |||||||||||||
| Named Executive Officers | ||||||||||||||
| Carol Tomé | 442,022 | 13,036 | 455,058 | |||||||||||
| Brian Dykes | 19,529 | — | 19,529 | |||||||||||
|
Brian Newman
(5)
|
38,931 | 65,751 | 104,682 | |||||||||||
| Nando Cesarone | 72,271 | 1 | 72,272 | |||||||||||
| Kate Gutmann | 176,861 | — | 176,861 | |||||||||||
| Bala Subramanian | 26,947 | — | 26,947 | |||||||||||
| Non-Employee Directors | ||||||||||||||
| Rodney Adkins | 22,119 | — | 22,119 | |||||||||||
| Eva Boratto | 5,398 | 1,400 | 6,798 | |||||||||||
| Michael Burns | 39,921 | — | 39,921 | |||||||||||
| Kevin Clark | 408 | 228 | 636 | |||||||||||
| Wayne Hewett | 5,398 | 868 | 6,266 | |||||||||||
| Angela Hwang | 5,780 | — | 5,780 | |||||||||||
| Kate Johnson | 5,056 | — | 5,056 | |||||||||||
| William Johnson | 38,347 | 5,160 | 43,507 | |||||||||||
| Franck Moison | 13,257 | — | 13,257 | |||||||||||
| Christiana Smith Shi | 11,165 | — | 11,165 | |||||||||||
| Russell Stokes | 5,056 | 400 | 5,456 | |||||||||||
| Kevin Warsh | 24,406 | — | 24,406 | |||||||||||
| Current Executive Officers and Directors as a Group (20 persons) | 1,082,716 | 21,093 | 1,103,809 |
(6)
|
||||||||||
|
72
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Audit Committee Matters | ||
|
What am I voting on?
Ratify the Audit Committee’s (as used in this Audit Committee Matters section, the “Committee”) appointment of Deloitte & Touche LLP (“Deloitte”) to serve as our independent registered public accounting firm for 2025.
Board’s Recommendation:
Vote
FOR
the ratification of the appointment of Deloitte as our independent registered public accounting firm for
2025.
Vote Required:
Approval by a majority of the voting power of the shares present in person or by proxy and entitled to vote on the proposal.
|
||
|
73
|
|||||||
|
74
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
2024
|
2023 | |||||||||||||
|
Audit Fees
(1)
|
$ | 21,881,000 | $ | 20,228,000 | ||||||||||
|
Audit-Related Fees
(2)
|
$ | 2,610,000 | $ | 1,615,000 | ||||||||||
| Total Audit and Audit-Related Fees | $ | 24,491,000 | $ | 21,843,000 | ||||||||||
|
Tax Fees
(3)
|
$ | 139,000 | $ | 98,000 | ||||||||||
|
All Other Fees
(4)
|
$ | 203,000 | $ | 6,000 | ||||||||||
| Total Fees | $ | 24,833,000 | $ | 21,947,000 | ||||||||||
| Services Provided by Deloitte | ||
|
75
|
|||||||
| Shareowner Proposals | ||
| Shareowner Proposal | ||
|
76
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Response of UPS’s Board | ||
|
77
|
|||||||
|
78
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Shareowner Proposal | ||
|
79
|
|||||||
| Response of UPS’s Board | ||
|
80
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
|
81
|
|||||||
|
Important Information About Voting at the 2025 Annual Meeting
|
||
| What is included in the proxy materials, and why am I receiving them? | ||
| Why did some shareowners receive a Notice of Internet Availability of Proxy Materials while others received a printed set of proxy materials? | ||
| Can I receive future proxy materials and annual reports electronically? | ||
| Who is entitled to vote? | ||
| To how many votes is each share of common stock entitled? | ||
|
82
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| How do I vote before the Annual Meeting? | ||
|
BENEFICIAL SHAREOWNER VOTING OPTIONS
If you are a beneficial owner, you will receive instructions from your bank, broker or other nominee that you must follow in order for your shares to be voted. Many of these institutions offer telephone and Internet voting. If your voting instruction form or Notice indicates that you may vote these shares through www.proxyvote.com, you will need the 16-digit control number indicated on that form or Notice. If you did not receive a 16-digit control number, please contact your bank, broker or other nominee at least five days before the Annual Meeting and obtain a legal proxy to be able to participate in or vote at the Annual Meeting.
|
||
| Can I revoke my proxy or change my vote? | ||
| How many votes do you need to hold the Annual Meeting? | ||
| What happens if I do not provide voting instructions or if a nominee is unable to stand for election? | ||
|
83
|
|||||||
| Will my shares be voted if I do not vote through the Internet, by telephone or by signing and returning my proxy card? | ||
| What is the vote required for each proposal to pass, and what is the effect of abstentions and broker non-votes on each of the proposals? | ||
|
Proposal
Number
|
Item |
Vote Required for
Approval
|
Abstentions |
Uninstructed
shares
|
||||||||||
| 1. |
Election of 12 directors
|
Majority of votes cast | No effect | No effect | ||||||||||
| 2. |
Advisory vote to approve NEO compensation
|
Majority of the voting power of the shares represented at the meeting and entitled to vote on the proposal
|
Same as a vote against
|
No effect | ||||||||||
|
3.
|
Ratification of independent registered public accounting firm |
Majority of the voting power of the shares represented at the meeting and entitled to vote on the proposal
|
Same as a vote against
|
No effect
|
||||||||||
|
4. - 5.
|
Shareowner proposals |
Majority of the voting power of the shares represented at the meeting and entitled to vote on the proposal
|
Same as a vote against
|
No effect | ||||||||||
| How do I attend and vote at the Annual Meeting? | ||
|
84
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| How can I submit a question at or prior to the Annual Meeting? | ||
| What if I have technical difficulties or trouble accessing the virtual Annual Meeting? | ||
| What does it mean if I receive more than one Notice, proxy card or voting instruction form? | ||
| When and where will I be able to find the voting results? | ||
|
85
|
|||||||
|
Other Information for Shareowners
|
||
| Proposals for Inclusion in the Proxy Statement for the 2026 Annual Meeting | ||
| Director Nominations for Inclusion in the Proxy Statement for the 2026 Annual Meeting | ||
|
86
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
| Other Proposals or Director Nominations for Presentation at the 2026 Annual Meeting | ||
|
87
|
|||||||
|
88
|
|
Notice of Annual Meeting of Shareowners and 2025 Proxy Statement
|
||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|